Reproductive factors, heterogeneity, and breast tumor subtypes in women of Mexican descent

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 10, 2013, Pages 1853-1861

  Martinez, Maria Elena ^a,b   Wertheim, Betsy C ^c   Natarajan, Loki ^a,b   Schwab, Richard ^a   Bondy, Melissa ^e   Daneri Navarro, Adrian ^g   Meza Montenegro, Maria Mercedes ^h   Gutierrez Millan, Luis Enrique ⁱ   Brewster, Abenaa ^f   Komenaka, Ian K ^d   Thompson, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d MARICOPA MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g Universidad of Guadalajara   (Mexico)

^h INSTITUTO TECNOLÓGICO DE SONORA   (Mexico)

ⁱ Universidad Estatal de Sonora   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; BREAST TUMOR; CANCER RISK; COMPARATIVE STUDY; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUATION; MEXICO; PARITY; PRIMIGRAVIDA; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; FEMALE; HUMANS; MEXICAN AMERICANS; MEXICO; MIDDLE AGED; PREGNANCY; PREVALENCE; REPRODUCTIVE HISTORY; RISK FACTORS; UNITED STATES;

EID: 84886413477     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0560     Document Type: Article

References (36)

1. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133-40.
2. Clavel-Chapelon F, Group EN. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 2002;13:831-8.
3. Chavez-MacGregor M, Elias SG, Onland-Moret NC, van der Schouw YT, Van Gils CH, Monninkhof E, et al. Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol Biomarkers Prev 2005;14:799-804.
4. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
5. Martinez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we learn about disease etiology from case-case analyses? Lessons frombreastcancer.CancerEpidemiolBiomarkers Prev2010;19:2710-4.
6. Martinez ME, Gutierrez-Millan LE, Bondy M, Daneri-Navarro A, Meza- Montenegro M, Anduro-Corona I, et al. Comparative Study of Breast Cancer in Mexican and Mexican-American Women. Health 2010;2: 1040-8.
7. Dowsett M. Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. EndocrRelat Cancer 2001;8:191-5.
8. Cruz GI, Martinez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M, et al. Hypothesized role of pregnancy hormones on HER2- breast tumor development. Breast Cancer Res Treat 2013;137:237-46.
9. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008;109:123-39.
10. Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, Blake-Cerda M, Arce C, Motola-Kuba D, et al. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 2011;117:3658-69.
11. Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 2011;20:1883-91.
12. Banegas MP, Leng M, Graubard BI, Morales LS. The risk of developing invasive breast cancer in Hispanic women: a look across Hispanic subgroups. Cancer 2013;119:1373-80.
13. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch InternMed2003;163: 49-56.
14. De Waard F. Endocrine aspects of cancer: an epidemiological approach. J Steroid Biochem Mol Biol 1991;40:15-9.
15. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, et al. Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 2008;167:230-9.
16. Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat 2013;137:579-87.
17. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011;103:250-63.
18. Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, et al. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 2009;11:R31.
19. Redondo CM, Gago-Dominguez M, Ponte SM, Castelo ME, Jiang X, Garcia AA, et al. Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS ONE 2012;7:e40543.
20. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011;22: 399-405.
21. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski- Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011;103:470-7.
22. Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 2009;20:1071-82.
23. Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, et al. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat 2012;131:159-67.
24. Xing P, Li JG, Jin F. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol 2010;27:926-31.
25. Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 2010;12:R35.
26. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007;16:439-43.
27. Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK, et al. Higher parity andshorter breastfeedingduration: association with triplenegative phenotype of breast cancer. Cancer 2010;116:4933-43.
28. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 2008;113:1521-6.
29. Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, et al. Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 2011;130:587-97.
30. Collaborative Group on Hormonal Factors in Breast C. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without the disease. Lancet 2002; 360:187-95.
31. Russo J, Russo IH. Cellular basis of breast cancer susceptibility. Oncol Res 1999;11:169-78.
32. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006;8:R43.
33. Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 2009;18:1157-66.
34. Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, et al. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a casecontrol study. Cancer Epidemiol Biomarkers Prev 2008;17:1723-30.
35. Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast 2013;22:344-50.
36. Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat 2013;137:307-14.